Centronuclear (myotubular) myopathy

Orphanet Journal of Rare Diseases

Volumn 3, Issue 1, 2008, Pages

  Jungbluth, Heinz ^a,b   Wallgren Pettersson, Carina ^c,d   Laporte, Jocelyn ^e,f,g,h,i  

^a ST THOMAS HOSPITAL   (United Kingdom)

^b KING'S COLLEGE LONDON   (United Kingdom)

^c UNIVERSITY OF HELSINKI   (Finland)

^d FOLKHÄLSAN RESEARCH CENTER   (Finland)

^e INSTITUT DE GÉNÉTIQUE ET DE BIOLOGIE MOLÉCULAIRE ET CELLULAIRE   (France)

^f INSERM   (France)

^g CNRS   (France)

^h UNIVERSITÉ DE STRASBOURG   (France)

ⁱ l'alimentation et l'Environnement   (France)

Author keywords

[No Author keywords available]

Indexed keywords

MYOTUBULARIN; NON RECEPTOR PROTEIN TYROSINE PHOSPHATASE; UNCLASSIFIED DRUG;

GENETICS; HUMAN; INFANT; MALE; MIDDLE AGED; MYOPATHY; PATHOLOGY; RECESSIVE GENE; REVIEW; SKELETAL MUSCLE; X CHROMOSOME; X CHROMOSOME LINKED DISORDER;

CHROMOSOMES, HUMAN, X; GENES, RECESSIVE; GENETIC DISEASES, X-LINKED; HUMANS; INFANT; MALE; MIDDLE AGED; MUSCLE, SKELETAL; MYOPATHIES, STRUCTURAL, CONGENITAL; PROTEIN TYROSINE PHOSPHATASES, NON-RECEPTOR;

EID: 54849411236     PISSN: None     EISSN: 17501172     Source Type: Journal    
DOI: 10.1186/1750-1172-3-26     Document Type: Review

References (162)

1. VA McKusick, Mendelian Inheritance in Man. A Catalog of Human Genes and Genetic Disorders Baltimore, London: The Johns Hopkins University Press 12 1998
2. Myotubular myopathy. AJ Spiro GM Shy NK Gonatas, Archives of Neurology 1966 14 1 14 4954227
3. Congenital nemaline myopathy: a longitudinal study. C Wallgren-Pettersson, J Neurol Sci University of Helsinki, Commentationes Physico-Mathematicae1990 111/1990 1989 89 1 1 14 Dissertationes 30: 102 10.1016/0022-510X(89)90002-6 2926439
4. The prevalence of inherited neuromuscular disease in Northern Ireland. MI Hughes EM Hicks NC Nevin VH Patterson, Neuromuscul Disord 1996 6 69 73 10.1016/0960-8966(94)00017-4 8845721
5. Neuromuscular disorders in childhood: a descriptive epidemiological study from Western Sweden. N Darin M Tulinius, Neuromuscul Disord 2000 10 1 9 10.1016/S0960-8966(99)00055-3 10677857
6. Familial "myotubular" myopathy. GK van Wijngaarden P Fleury J Bethlem H Meijer, Neurology 1969 19 901 908 5816884
7. Familial neuromuscular disease with "myotubes.". KR Meyers HM Golomb JL Hansen VA McKusick, Clin Genet 1974 5 327 337 4136736
8. X-linked myotubular myopathy with fatal neonatal asphyxia. PG Barth GK van Wijngaarden J Bethlem, Neurology 1975 25 531 536 1168872
9. X-linked recessive myotubular myopathy. I. Clinical and pathologic findings in a family. MW Ambler C Neave BG Tutschka SM Pueschel JM Orson DB Singer, Hum Pathol 1984 15 566 574 10.1016/S0046-8177(84)80011-8 6539297
10. Congenital centronuclear (myotubular) myopathy: a clinical, pathological and genetic study in eight children. JZ Heckmatt CA Sewry D Hodes V Dubowitz, Brain 1985 108 941 964 10.1093/brain/108.4.941 4075080
11. X-linked myotubular myopathy: intrafamilial variability and normal muscle biopsy in a heterozygous female. LD Keppen MM Husain RC Woody, Clin Genet 1987 32 95 99 3652496
12. X-linked myotubular myopathy: clinical and pathological findings in a family. A Oldfors M Kyllerman J Wahlström C Darnfors KG Henriksson, Clin Genet 1989 36 5 14 2670345
13. Severe neonatal asphyxia due to X-linked centronuclear myopathy. SE Braga A Gerber C Meier A Weiersmueller A Zimmermann U Herrmann S Liechti H Moser, Eur J Pediatr 1990 150 132 135 10.1007/BF02072056 2279510
14. Centronuclear myopathy and type 1 hypotrophy without central nuclei. Distinct nososlogic entities? WD Lo RJ Barohn RJ Bobulski Bobulski J Kean JR Mendell, Arch Neurol 1990 47 273 276 2310312
15. Maternal muscle biopsy in X-linked recessive centronuclear (myotubular) myopathy. GN Breningstall WD Grover HG Marks, Am J Med Genet 1991 39 1 13 18 10.1002/ajmg.1320390105 1867257
16. X-linked myotubular myopathy: a case report of prenatal and perinatal aspects. RW Tyson SP Ringel DK Manchester RH Shikes SI Goodman, Pediatr Pathol 1992 12 535 543 10.3109/15513819209024203 1409152
17. Report on the 20th ENMC sponsored international workshop: myotubular/centronuclear myopathy. C Wallgren-Pettersson N Thomas, Neuromuscul Disord 1994 4 71 74 10.1016/0960-8966(94)90050-7 8173354
18. The myotubular myopathies: differential diagnosis of the X-linked recessive, autosomal dominant and autosomal recessive forms and present state of DNA studies. C Wallgren-Pettersson A Clarke F Samson M Fardeau V Dubowitz H Moser T Grimm RJ Barohn PG Barth, J Med Genet 1995 32 673 679 8544184
19. Genotype-phenotype correlations in X-linked myotubular myopathy. M McEntagart G Parsons A Buj-Bello V Biancalana I Fenton M Little M Krawczak N Thomas G Herman A Clarke C Wallgren-Pettersson, Neuromuscul Disord 2002 12 939 946 10.1016/S0960-8966(02)00153-0 12467749
20. Thin ribs on chest X-ray: a useful sign in the differential diagnosis of the floppy newborn. JP Osborne EG Murphy A Hill, Dev Med Child Neurol 1983 25 343 345 6873496
21. 3 examples of fetal genetic neuromuscular disorders which lead to hydramnion. AH Teeuw PG Barth L van Sonderen HA Zondervan, Ned Tijdschr Geneeskd 1993 137 908 913 8492834
22. X-linked myotubular myopathy - A long-term follow up study. PG Barth V Dubowitz, Eur J Ped Neurol 1998 1 49 56 10.1016/1090-3798(98)01004-9
23. High stature in neonatal myotubular myopathy. J-C LeGuennec J-P Bernier J Lamarche, Acta Paediatr Scand 1988 77 610 611 10.1111/j.1651-2227.1988.tb10714. x 3394519
24. X-linked myotubular myopathy: clinical observations in ten additional cases. M Joseph GS Pai KR Holden G Herman, Am J Med Genet 1995 59 168 173 10.1002/ajmg.1320590211 8588581
25. Neonatal myotubular myopathy: neuropathy and failure of postnatal maturation of fetal muscle. HB Sarnat SI Roth JF Jimenez, Can J Neurol Sci 1981 8 313 320 7326611
26. Medical complications in long-term survivors with X-linked myotubular myopathy. GE Herman M Finegold W Zhao B de Gouyon A Metzenberg, J Pediatr 1999 134 206 214 10.1016/S0022-3476(99)70417-8 9931531
27. X-linked myotubular myopathy in a family with three adult survivors. S Yu J Manson S White A Bourne H Waddy M Davis E Haan, Clin Genet 2003 64 148 152 10.1034/j.1399-0004.2003.00118.x 12859411
28. Characterisation of mutations in 77 patients with X-linked myotubular myopathy, including a family with a very mild phenotype. V Biancalana O Caron S Gallati F Baas W Kress G Novelli MR Dàpice C Lagier-Tourenne A Buj-Bello NB Romero JL Mandel, Hum Genet 2003 112 135 142 12522554
29. Unusual good prognosis for X-linked myotubular myopathy. S Chanzy MC Routon S Moretti C de Gennes JC Mselati, Arch Pediatr 2003 10 707 709 10.1016/S0929-693X(03)00287-2 12922003
30. Deletions in Xq28 in two boys with myotubular myopathy and abnormal genital development define a new contiguous gene syndrome in a 430 kb region. LJ Hu J Laporte W Kress P Kioschis R Siebenhaar A Poustka M Fardeau A Metzenberg EA Janssen N Thomas JL Mandel N Dahl, Hum Mol Genet 1999 5 139 143 10.1093/hmg/5.1.139
31. CXorf6 is a causative gene for hypospadias. M Fukami Y Wada K Miyabayashi I Nishino T Hasegawa A Nordenskjöld G Camerino C Kretz A Buj-Bello J Laporte G Yamada K Morohashi T Ogata, Nat Genet 2006 38 12 1369 1371 10.1038/ng1900 17086185
32. Centronuclear myopathy heterogeneity: distinction of clinical types by myosin isoform patterns. JA Sawchak JH Sher MG Norman RW Kula SA Shafiq, Neurology 1991 41 135 140 1824643
33. A clinical and genetic study of a manifesting heterozygote with X-linked myotubular myopathy. SR Hammans DO Robinson C Moutou CR Kennedy NR Dennis PJ Hughes DW Ellison, Neuromuscul Disord 2000 10 133 137 10.1016/S0960-8966(99) 00073-5 10714588
34. Report of the 72nd ENMC International Workshop on Myotubular Myopathy, Hilversum, The Netherlands, 1-3 October 1999. C Wallgren-Pettersson, Neuromuscul Disord 2000 10 521 525
35. Skewed X-inactivation in a manifesting carrier of X-linked myotubular myopathy and in her non-manifesting carrier mother. SM Tanner KH Orstavik M Kristiansen D Lev T Lerman-Sagie M Sadeh S Liechti-Gallati, Hum Genet 1999 104 249 253 10.1007/s004390050943 10323249
36. Limb girdle and facial weakness in female carriers of X-linked myotubular myopathy mutations. IJ Sutton JB Winer AN Norman S Liechti-Gallati F MacDonald, Neurology 2001 57 900 902 11552027
37. Early and severe presentation of X-linked myotubular myopathy in a girl with skewed X-inactivation. H Jungbluth CA Sewry A Buj-Bello M Kristiansen KH Orstavik A Kelsey AY Manzur E Mercuri C Wallgren-Pettersson F Muntoni, Neuromuscul Disord 2003 13 55 59 10.1016/S0960-8966(02)00194-3 12467733
38. X-linked myotubular myopathy in a female infant caused by a new MTM1 gene mutation. U Schara W Kress J Tucke W Mortier, Neurology 2003 60 1363 1365 10.1001/archneur.60.10.1363 12707446
39. X-inactivation patterns in carriers of X-linked myotubular myopathy. M Kristiansen GP Knudsen SM Tanner M McEntagart H Jungbluth F Muntoni C Sewry S Gallati KH Orstavik C Wallgren-Pettersson, Neuromuscul Disord 2003 13 468 471 10.1016/S0960-8966(03)00067-1 12899873
40. Myotubular myopathy in a girl with a deletion at Xq27-q28 and unbalanced X-inactivation assigns the MTM1 gene to a 600-kb region. N Dahl LJ Hu M Chery M Fardeau S Gilgenkrantz Nivelon-Chevallier I Sidaner-Noisette F Mugneret JB Gouyon A Gal, Am J Hum Genet 1995 56 1108 1115 7726166
41. Centronuclear myopathy: clinical, morphological and genetic characters. A review of 288 cases. MS De Angelis L Palmucci M Leone C Doriguzzi, J Neurol Sci 1991 103 2 9 10.1016/0022-510X(91)90275-C 1865227
42. Familial centronuclear myopathy: a clinical and pathological study. JH Sher AB Rimalovski TJ Athanassiades SM Aronson, Neurology 1967 17 727 742 15088533
43. Myotubular (centronuclear) (neuro-) myopathy. I. Clinical, genetical and morphological studies. H Radu I Killyen V Ionescu A Radu, Eur Neurol 1977 15 285 300 10.1159/000114815 913442
44. Familial centronuclear myopathy associated with "cardiomyopathy. ". W Verhiest JM Brucher P Goddeeris J Lauweryns H De Geest, Br Heart J 1976 38 504 509 131568 10.1136/hrt.38.5.504
45. Centronuclear myopathy: possible central nervous system origin. G Serratrice JF Pellissier MC Faugére JL Gastaut, Muscle Nerve 1978 1 62 69 10.1002/mus.880010109 752109
46. Familial centronuclear myopathy. L Pavone F Mollica A Grasso G Pero, Acta Neurol Scand 1980 62 33 40 7211157
47. Myopathy with pathological features of both centronuclear myopathy and multicore disease. RB Fitzsimons JG McLeod, J Neurol Sci 1982 57 395 405 10.1016/0022-510X(82)90044-2 7161626
48. On some myopathies with oculomotor involvement. JJ Martin, Acta Neurol Belg 1987 87 207 228 3673494
49. Problems in genetic counseling in a family with "atypical" centronuclear myopathy. B Müller ML Mostacciuolo GA Danieli T Grimm, Am J Med Genet 1989 32 417 419 10.1002/ajmg.1320320330 2729361
50. Clinical and histologic findings in autosomal centronuclear myopathy. PY Jeannet G Bassez B Eymard P Laforêt JA Urtizberea A Rouche P Guicheney M Fardeau NB Romero, Neurology 2004 62 9 1484 1490 15136669
51. Centronuclear myopathy in black African children-report of 4 cases. A Moosa AA Dawood, Neuropediatrics 1987 18 213 217 3696389
52. Histopathological aspects in ten patients with childhood onset. E Zanoteli AS Oliveira BH Kiyomoto B Schmidt AA Gabbai, Arq Neuropsiquiatr 1998 56 1 8 9686113
53. Temporomandibular joint involvement in a patient with centronuclear myopathy. E Zanoteli AS Guimaraes RJ Martins HK Yamashita CS Toledo AS Oliveira AA Gabbai, Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2000 90 118 121 10.1067/moe.2000.107051 10884647
54. Foot deformity in myotubular myopathy. Pathology of intrinsic foot musculature. M Siegel, Arch Neurol 1983 40 589 6615293
55. Centronuclear myopathy. Complete review of the literature apropos of a case. M Pages JB Cesari AM Pages, Ann Pathol 1982 2 301 310 6760877
56. Life-threatening congestive heart failure as the presentation of centronuclear myopathy. SM Gospe Jr DL Armstrong MV Gresik HK Hawkins, Pediatr Neurol 1987 3 117 120 10.1016/0887-8994(87)90040-3 3508053
57. Pathological anatomy of the heart in myopathies and infantile muscular atrophies. J Bataille F Guillon A Urtizberea B Estournet S Richard A Barois, Ann Med Interne (Paris) 1991 142 5 8 2048876
58. Myotubular myopathy: clinical, electrophysiological and histological study of a case. JL Alonso MJ Cavaliere SM Gagioti AA Atalla I Nascimento JC Dias, Arq Neuropsiquiatr 1981 39 450 472 7340762
59. Mutations in amphiphysin 2 (BIN1) disrupt interaction with dynamin 2 and cause autosomal recessive centronuclear myopathy. AS Nicot A Toussaint V Tosch C Kretz C Wallgren-Pettersson E Iwarsson H Kingston JM Garnier V Biancalana A Oldfors JL Mandel J Laporte, Nat Genet 2007 39 9 1134 1139 10.1038/ng2086 17676042
60. Targeted disruption of the murine Bin1/Amphiphysin II gene does not disable endocytosis but results in embryonic cardiomyopathy with aberrant myofibril formation. AJ Muller JF Baker JB DuHadaway K Ge G Farmer PS Donover R Meade C Reid R Grzanna AH Roach N Shah AP Soler GC Prendergast, Mol Cell Biol 2003 23 12 4295 4306 12773571 10.1128/MCB.23.12.4295-4306.2003
61. Familial centronuclear myopathy: a clinical and pathological study. E Reske-Nielsen O Hein-Sørensen P Vorre, Acta Neurol Scand 1987 76 115 122 3673497
62. Myopathie centronucléaire autosomique dominante. X Ferrer C Vital M Coquet B Deleplanque E Ellie A Lagueny J Julien, Rev Neurol (Paris) 1992 148 622 630 1295057
63. [Late centronuclear myopathy: autosomal dominant form]. L Cartier JE Hernandez, Revista Medica de Chile 1996 124 209 216 9213890
64. Genuine myotubular myopathy. L Edström R Wroblewski WGP Mair, Muscle Nerve 1982 5 604 613 10.1002/mus.880050804 7155173
65. Centronuclear myopathy-an inherited neuromuscular disorder. A report of 3 cases. H Isaacs ME Badenhorst, S Afr Med J 1991 80 247 250 1887355
66. Type I muscle fiber atrophy and central nuclei. A rare familial neuromuscular disease. G Karpati S Carpenter RF Nelson, J Neurol Sci 1970 10 489 500 10.1016/0022-510X(70)90027-4 4910660
67. Centronuclear myopathy with autosomal dominant inheritance. JG McLeod WDEC Baker AK Lethlean CD Shorey, J Neurol Sci 1972 15 375 387 10.1016/0022-510X(72)90166-9 5016690
68. Centronuclear myopathy: disease entity or syndrome? Light- and electron microscopic study of two cases and review of the literature. SS Schochet H Zellweger V Ionasescu WF McCormick, J Neurol Sci 1972 16 215 228 10.1016/0022-510X(72)90091-3 5037445
69. "Myotubular myopathy" and "type I fiber atrophy" in a family. M Kinoshita E Satoyoshi N Matsuo, J Neurol Sci 1975 26 575 582 10.1016/0022-510X(75)90058-1 1206433
70. Centronucleäre Myopathie mit autosomal dominanten Erbgang. W Mortier E Michaelis J Becker L Gerhard, Humangenetik 1975 27 199 215 10.1007/BF00278346 1150240
71. Forme familiale de myopathie centronucleaire de l'adulte. B Pépin J Mikol B Goldstein M Haguenau S Godlewski, Rev Neurol (Paris) 1976 132 845 857 1013570
72. Crural hypertrophy associated with centronuclear myopathy. P Bill G Cole NSF Proctor D Saffer A Botes, J Neurol Neurosurg Psychiat 1979 42 542 547 157387
73. Severe neonatal centronuclear myopathy with autosomal dominant inheritance. CF Torres RC Griggs JP Goetz, Arch Neurol 1985 42 1011 1014 2994607
74. Centronuclear myopathy with unusual clinical picture. MG Lovaste D Aldovini G Ferrari, Eur Neurol 1987 26 153 160 10.1159/000116328 3569369
75. Autosomal dominant centronuclear myopathy: report of a new family with clinical features simulating facioscapulohumeral syndrome. KJ Felice ML Grunnet, Muscle Nerve 1997 20 1194 1196 10.1002/(SICI)1097-4598(199709)20:9<1194:: AID-MUS19>3.0.CO;2-T 9270681
76. Mutations in dynamin 2 cause dominant centronuclear myopathy. M Bitoun S Maugenre PY Jeannet E Lacène X Ferrer P Laforêt JJ Martin J Laporte H Lochmüller AH Beggs M Fardeau B Eymard NB Romero P Guicheney, Nat Genet 2005 37 11 1207 1209 10.1038/ng1657 16227997
77. Characterization of the muscle involvement in dynamin 2-relatedcentronuclear myopathy. D Fischer M Herasse M Bitoun Barragan-Campos J Chiras P Laforet M Fardeau B Eymard P Guicheney NB Romero, Brain 2006 129 1463 1469 10.1093/brain/awl071 16585051
78. MRI in DNM2-related centronuclear myopathy: evidence for highly selective muscle involvement. J Schessl L Medne Y Hu Y Zou MJ Brown JT Huse DA Torigian H Jungbluth HH Goebel CG Bönnemann, Neuromuscul Disord 2007 17 1 28 32 10.1016/j.nmd.2006.09.013 17134899
79. Subtle central and peripheral nervous system abnormalities in a family with centronuclear myopathy and a novel dynamin 2 gene mutation. A Echaniz-Laguna AS Nicot S Carré J Franques C Tranchant N Dondaine V Biancalana JL Mandel J Laporte, Neuromuscul Disord 2007 17 11-12 955 959 10.1016/j.nmd.2007.06.467 17825552
80. Mutations in the pleckstrin homology domain of dynamin 2 cause dominant intermediate Charcot-Marie-Tooth disease. S Züchner M Noureddine M Kennerson K Verhoeven K Claeys P De Jonghe J Merory SA Oliveira MC Speer JE Stenger G Walizada D Zhu MA Pericak-Vance G Nicholson V Timmerman JM Vance, Nat Genet 2005 37 3 289 294 10.1038/ng1514 15731758
81. Dynamin 2 mutations cause sporadic centronuclear myopathy with neonatal onset. M Bitoun JA Bevilacqua B Prudhon S Maugenre AL Taratuto S Monges F Lubieniecki C Cances E Uro-Coste M Mayer M Fardeau NB Romero P Guicheney, Ann Neurol 2007 62 6 666 670 10.1002/ana.21235 17932957
82. Centronuclear myopathy due to a de novo dominant mutation in the skeletal muscle ryanodine receptor (RYR1) gene. H Jungbluth H Zhou CA Sewry S Robb S Treves M Bitoun P Guicheney A Buj-Bello C Bönnemann F Muntoni, Neuromuscul Disord 2007 17 4 338 345 10.1016/j.nmd.2007.01.016 17376685
83. Minicore myopathy with ophthalmoplegia caused by mutations in the ryanodine receptor type 1 gene. H Jungbluth H Zhou L Hartley B Halliger-Keller S Messina C Longman M Brockington SA Robb V Straub T Voit M Swash A Ferreiro G Bydder CA Sewry C Müller F Muntoni, Neurology 2005 65 12 1930 1935 10.1212/01.wnl.0000188870.37076.f2 16380615
84. Multi-minicore Disease. H Jungbluth, Orphanet J Rare Dis 2007 2 3 17210076 10.1186/1750-1172-2-3
85. Development of malignant hyperthermia during mitral valve replacement. RD Quinn WE Pae SA McGary GS Wickey, Ann Thorac Surg 1992 53 1114 1116 1596140
86. X-linked myotubular myopathy (MTM1): evidence for linkage to Xq28 markers. NST Thomas M Sarfarazi K Roberts, Cytogenet Cell Genet 1987 46 (Abstr) 704.
87. X-linked myotubular myopathy: a linkage study. C Darnfors HE Larsson A Oldfors M Kyllerman KH Gustavson G Bjursell J Wahlstroem, Clin Genet 1990 37 335 340 1972354
88. X-linked neonatal myotubular myopathy: one recombination detected with polymorphic DNA markers from Xq28. A-E Lehesjoki E-M Sankila J Miao M Somer R Salonen J Rapola A de la Chapelle, J Med Genet 1990 27 288 291 1972196
89. A linkage study of a large pedigree with X-linked centronuclear myopathy. J Starr M Lamont J Iselius J Harvey J Heckmatt, J Med Genet 1990 27 281 283 2352255
90. X-linked neonatal centronuclear/myotubular myopathy: evidence for linkage to Xq28 DNA marker loci. NST Thomas H Williams G Cole K Roberts A Clarke S Liechti-Gallati S Braga A Gerber C Meier H Moser, J Med Genet 1990 27 284 287 2352256
91. X-linked centronuclear myopathy: mapping the gene to Xq28. S Liechti-Gallati B Müller T Grimm W Kress C Mueller E Boltshauser H Moser S Braga, Neuromuscul Disord 1991 1 239 245 10.1016/0960-8966(91)90096-B 1822801
92. X-linked myotubular myopathy (MTM1) mapped between DXS304 and DXS305, closely linked to the DXS455 VNTR and a new, highly informative microsatellite marker. N Dahl F Samson NST Thomas LJ Hu W Gong G Herman J Laporte P Kioschis A Poustka JL Mandel, J Med Genet 1994 31 922 924 7891372
93. Prenatal diagnosis of X-linked centronuclear myopathy by linkage analysis. S Liechti-Gallati G Wolff K Uwe-Peter S Braga, Pediatr Res 1993 33 201 204 8433896
94. The gene for X-linked myotubular myopathy is located in a 8 Mb region at the border of Xq27.3 and Xq28. EA Janssen GW Hensels BA van Oost BC Hamel S Kemp F Baas JW Weber PG Barth PA Bolhuis, Neuromuscul Disord 1994 4 455 461 10.1016/0960-8966(94)90084-1 7881289
95. A gene mutated in X-linked myotubular myopathy defines a new putative tyrosine phosphatase family conserved in yeast. J Laporte LJ Hu C Kretz JL Mandel P Kioschis JF Coy SM Klauck A Poustka N Dahl, Nature Genet 1996 13 175 182 10.1038/ng0696-175 8640223
96. Mutations in the MTM1 gene implicated in X-linked myotubular myopathy. ENMC International Consortium on Myotubular Myopathy. European Neuro-Muscular Center. J Laporte C Guiraud-Chaumeil MC Vincent JL Mandel SM Tanner S Liechti-Gallati C Wallgren-Pettersson N Dahl W Kress PA Bolhuis M Fardeau F Samson E Bertini, Hum Mol Genet 1997 6 1505 1511 10.1093/hmg/6.9.1505 9305655
97. MTM1 Mutations in X-linked myotubular myopathy. J Laporte V Biancalana SM Tanner W Kress V Schneider Wallgren-Pettersson F Herger A Buj-Bello F Blondeau S Liechti-Gallati JL Mandel, Hum Mutat 2000 15 393 409 10.1002/(SICI)1098- 1004(200005)15:5<393::AID-HUMU1>3.0.CO;2-R 10790201
98. Characterization of 34 novel and six known MTM1 gene mutations in 47 unrelated X-linked myotubular myopathy patients. SM Tanner V Schneider NS Thomas A Clarke L Lazarou S Liechti-Gallati, Neuromuscul Disord 1999 9 41 49 10.1016/S0960-8966(98)00090-X 10063835
99. Characterization of mutations in fifty North American patients with X-linked myotubular myopathy. GE Herman K Kopacz W Zhao PL Mills A Metzenberg S Das, Hum Mutat 2002 19 114 121 10.1002/humu.10033 11793470
100. Characterization of MTM1 mutations in 31 Japanese families with myotubular myopathy, including a patient carrying 240 kb deletion in Xq28 without male hypogenitalism. TC Tsai H Horinouchi S Noguchi N Minami K Murayama YK Hayashi I Nonaka I Nishino, Neuromuscul Disord 2005 5 3 245 252 10.1016/j.nmd.2004.12.005
101. Rapid scanning of myotubularin (MTM1) gene by denaturing high-performance liquid chromatography (DHPLC). E Flex A De Luca MR D'Apice A Buccino B Dallapiccola G Novelli, Neuromuscul Disord 2002 12 501 505 10.1016/S0960- 8966(01)00328-5 12031625
102. th Workshop of the International Consortium on Myotubular Myopathy). E Bertini V Biancalana A Bolino A Buj-Bello M Clague P Guicheney H Jungbluth W Kress A Musaro N Nandurkar L Pirola N Romero J Senderek U Suter C Sewry H Tronchere C Wallgren-Pettersson MJ Wishart J Laporte, Neuromuscul Disord 2004 14 387 396 10.1016/j.nmd.2004.04.002 15145343
103. Characterization of mutations in the myotubularin gene in twenty six patients with X-linked myotubular myopathy. BM De Gouyon W Zhao J Laporte JL Mandel A Metzenberg GE Herman, Hum Mol Genet 1997 6 1499 1504 10.1093/hmg/6.9.1499 9285787
104. MTM1 gene mutations in Japanese patients with the severe infantile form of myotubular myopathy. I Nishino N Minami O Kobayashi M Ikezawa Y Goto K Arahata I Nonaka, Neuromuscul Disord 1998 8 453 458 10.1016/S0960-8966(98)00075- 3 9829274
105. A novel mutation in exon b (R259C) of the MTM1 gene is associated with a mild myotubular myopathy. A Donnelly E Haan J Manson J Mulley, Hum Mutat 1998 11 4 334 10.1002/(SICI)1098-1004(1998)11:4<334::AID-HUMU20>3.0.CO;2-# 10215413
106. Identification of novel mutations in the MTM1 gene causing severe and mild forms of X-linked myotubular myopathy. A Buj-Bello V Biancalana C Moutou J Laporte JL Mandel, Human Mutation 1999 14 320 325 10.1002/(SICI)1098- 1004(199910)14:4<320::AID-HUMU7>3.0.CO;2-O 10502779
107. A novel mutation (R27 1X) in the myotubularin gene causes a severe myotubular myopathy. A De Luca I Torrente M Mangino E Bertini B Dallapiccola G Novelli, Human Heredity 1999 49 59 60 10.1159/000022843 9858861
108. Extensive germinal mosaicism in a family with X linked myotubular myopathy simulates genetic heterogeneity. MC Vincent C Guiraud-Chaumeil J Laporte S Manouvrier-Hanu JL Mandel, J Med Genet 1998 35 241 243 9541111
109. Germline mosaicism in X-linked myotubular myopathy. BG Hane RC Rogers CE Schwartz, Clin Genet 1999 56 77 81 10.1034/j.1399-0004.1999.560111.x 10466421
110. Myofiber size correlates with MTM1 mutation type and outcome in X-linked myotubular myopathy. CR Pierson PB Agrawal J Blasko AH Beggs, Neuromuscul Disord 2007 17 7 562 568 17537630 10.1016/j.nmd.2007.03.010
111. Charcot-Marie-Tooth type 4B is caused by mutations in the gene encoding myotubularin-related protein-2. A Bolino M Muglia FL Conforti E LeGuern MA Salih DM Georgiou K Christodoulou I Hausmanowa-Petrusewicz P Mandich A Schenone A Gambardella F Bono A Quattrone M Devoto AP Monaco, Nat Genet 2000 25 17 19 10.1038/75542 10802647
112. Membrane association of myotubularin-related protein 2 is mediated by a pleckstrin homology-GRAM domain and a coiled-coil dimerization module. P Berger C Schaffitzel I Berger N Ban U Suter, Proc Natl Acad Sci USA 2003 100 21 12177 12182 14530412 10.1073/pnas.2132732100
113. Mutations in MTMR13, a new pseudophosphatase homologue of MTMR2 and Sbf1, in two families with an autosomal recessive demyelinating form of Charcot-Marie-Tooth disease associated with early-onset glaucoma. H Azzedine A Bolino T Taïeb N Birouk M Di Duca A Bouhouche S Benamou A Mrabet T Hammadouche T Chkili R Gouider R Ravazzolo A Brice J Laporte E LeGuern, Am J Hum Genet 2003 72 1141 1153 12687498 10.1086/375034
114. Mutation of the SBF2 gene, encoding a novel member of the myotubularin family, in Charcot-Marie-Tooth neuropathy type 4B2/11p15. J Senderek C Bergmann S Weber UP Ketelsen H Schorle S Rudnik-Schoneborn R Buettner E Buchheim K Zerres, Hum Mol Genet 2003 12 349 356 10.1093/hmg/ddg030 12554688
115. Characterization of the myotubularin dual specificity phosphatase gene family from yeast to human. J Laporte F Blondeau A Buj-Bello D Tentler C Kretz N Dahl JL Mandel, Hum Mol Genet 1998 7 1703 1712 10.1093/hmg/7.11.1703 9736772
116. Association of SET domain and myotubularin-related proteins modulates growth control. X Cui VI De R Slany A Miyamoto R Firestein ML Cleary, Nat Genet 1998 18 331 337 10.1038/ng0498-331 9537414
117. Myotubularin, a phosphatase deficient in myotubular myopathy, acts on phosphatidylinositol 3-kinase and phosphatidylinositol 3-phosphate pathway. F Blondeau J Laporte S Bodin Superti-Furga B Payrastre JL Mandel, Hum Mol Genet 2000 9 15 2223 2229 11001925
118. Myotubularin, a protein tyrosine phosphatase mutated in myotubular myopathy, dephosphorylates the lipid second messenger, phosphatidylinositol 3-phosphate. GS Taylor T Maehama JE Dixon, Proc Natl Acad Sci USA 2000 97 8910 8915 10900271 10.1073/pnas.160255697
119. Expression of myotubularin by an adenoviral vector demonstrates its function as a phosphatidylinositol 3-phosphate [PtdIns(3)P] phosphatase in muscle cell lines: involvement of PtdIns(3)P in insulin-stimulated glucose transport. C Chaussade L Pirola S Bonnafous F Blondeau S Brenz-Verca H Tronchère F Portis S Rusconi B Payrastre J Laporte E Van Obberghen, Mol Endocrinol 2003 17 2448 2460 10.1210/me.2003-0261 14500759
120. Myotubularin regulates the function of the late endosome through the gram domain-phosphatidylinositol 3,5-bisphosphate interaction. K Tsujita T Itoh T Ijuin A Yamamoto A Shisheva J Laporte T Takenawa, J Biol Chem 2004 279 13817 13824 10.1074/jbc.M312294200 14722070
121. Production of phosphatidylinositol 5-phosphate by the phosphoinositide 3-phosphatase myotubularin in mammalian cells. H Tronchère J Laporte C Pendariest C Chaussade L Liaubet L Pirola JL Mandel B Payrastre, J Biol Chem 2004 279 8 7404 7312
122. The myotubularin family: from genetic disease to phosphoinositide metabolism. J Laporte F Blondeau A Buj-Bello JL Mandel, Trends Genet 2001 17 221 228 10.1016/S0168-9525(01)02245-4 11275328
123. Identification of myotubularin as the lipid phosphatase catalytic subunit associated with the 3-phosphatase adapter protein, 3-PAP. HH Nandurkar M Layton J Laporte C Selan L Corcoran KK Caldwell Y Mochizuki PW Majerus CA Mitchell, Proc Natl Acad Sci USA 2003 100 8660 8665 12847286 10.1073/pnas.1033097100
124. Myotubularins, a large disease-associated family of cooperating catalytically active and inactive phosphoinositides phosphatases. J Laporte F Bedez A Bolino JL Mandel, Hum Mol Genet 2003 12 Spec No 2 R285 292 10.1093/hmg/ddg273 12925573
125. The myotubularin family of lipid phosphatases. MJ Clague O Lorenzo, Traffic 2005 6 12 1063 1069 10.1111/j.1600-0854.2005.00338.x 16262718
126. Myotubularin phosphatases: policing 3-phosphoinositides. FL Robinson JE Dixon, Trends Cell Biol 2006 16 8 403 412 10.1016/j.tcb.2006.06.001 16828287
127. The lipid phosphatase myotubularin is essential for skeletal muscle maintenance but not for myogenesis in mice. A Buj-Bello V Laugel N Messadeq H Zahreddine J Laporte JF Pellisier JL Mandel, Natl Acad Sci USA 2002 99 15060 15065 10.1073/pnas.212498399
128. Gene expression analyses in X-linked myotubular myopathy. S Noguchi M Fujita K Murayama R Kurokawa Nishino, Neurology 2005 65 5 732 737 10.1212/01.wnl.0000174625.67484.4d 16157907
129. Two novel mutations in dynamin-2 cause axonal Charcot-Marie-Tooth disease. GM Fabrizi M Ferrarini T Cavallaro I Cabrini R Cerini L Bertolasi N Rizzuto, Neurology 2007 69 3 291 295 10.1212/01.wnl.0000265820.51075.61 17636067
130. A novel mutation in the dynamin 2 gene in a Charcot-Marie-Tooth type 2 patient: clinical and pathological findings. M Bitoun T Stojkovic B Prudhon CA Maurage P Latour P Vermersch P Guicheney, Neuromuscul Disord 2008 18 4 334 338 10.1016/j.nmd.2008.01.005 18394888
131. Dynamin is required for F-actin assembly and pedestal formation by enteropathogenic Escherichia coli (EPEC). KE Unsworth P Mazurkiewicz F Senf M Zettl M McNiven M Way DW Holden, Cell Microbiol 2007 9 2 438 449 10.1111/j.1462-5822.2006.00801.x 16965516
132. Dynamin 2 binds gamma-tubulin and participates in centrosome cohesion. HM Thompson H Cao J Chen U Euteneuer MA McNiven, Nat Cell Biol 2004 6 4 335 342 10.1038/ncb1112 15048127
133. Role of dynamin in the formation of transport vesicles from the trans-Golgi network. SM Jones KE Howell JR Henley H Cao MA McNiven, Science 1998 279 5350 573 577 10.1126/science.279.5350.573 9438853
134. Amphiphysin II (SH3P9; BIN1), a member of the amphiphysin/Rvs family, is concentrated in the cortical cytomatrix of axon initial segments and nodes of ranvier in brain and around T tubules in skeletal muscle. MH Butler C David GC Ochoa Z Freyberg L Daniell D Grabs O Cremona P De Camilli, J Cell Biol 1997 137 6 1355 1367 9182667 10.1083/jcb.137.6.1355
135. Identification and characterization of a nerve terminal-enriched amphiphysin isoform. AR Ramjaun KD Micheva I Bouchelet PS McPherson, J Biol Chem 1997 272 26 16700 16706 10.1074/jbc.272.26.16700 9195986
136. BAR domains as sensors of membrane curvature: the amphiphysin BAR structure. BJ Peter HM Kent IG Mills Y Vallis PJ Butler PR Evans HT McMahon, Science 2004 303 5657 495 499 10.1126/science.1092586 14645856
137. Amphiphysin is necessary for organization of the excitation-contraction coupling machinery of muscles, but not for synaptic vesicle endocytosis in Drosophila. A Razzaq IM Robinson HT McMahon JN Skepper Y Su AC Zelhof AP Jackson NJ Gay CJ O'Kane, Genes Dev 2001 15 22 2967 2979 11711432 10.1101/gad.207801
138. Crystal structure of the amphiphysin-2 SH3 domain and its role in the prevention of dynamin ring formation. DJ Owen P Wigge Y Vallis JD Moore PR Evans HT McMahon, EMBO J 1998 17 18 5273 5285 9736607 10.1093/emboj/17.18.5273
139. Amphiphysin 2 (Bin1) and T-tubule biogenesis in muscle. E Lee M Marcucci L Daniell M Pypaert OA Weisz GC Ochoa K Farsad MR Wenk P De Camilli, Science 2002 297 5584 1193 1196 10.1126/science.1071362 12183633
140. A novel PtdIns3P and PtdIns(3,5)P2 phosphatase with an inactivating variant in centronuclear myopathy. V Tosch HM Rohde H Tronchère E Zanoteli N Monroy C Kretz N Dondaine B Payrastre JL Mandel J Laporte, Hum Mol Genet 2006 15 21 3098 3106 10.1093/hmg/ddl250 17008356
141. Centronuclear myopathy: extraocular and limb muscle findings in an adult. BJ Bergen MP Carry WB Wilson MT Barden SP Ringel, Muscle Nerve 1980 3 165 171 10.1002/mus.880030210 6445039
142. Muscle histochemistry in myotubular (centronuclear) myopathy. T Sasaki K Shikura K Sugai I Nonaka K Kumagai, Brain Dev 1989 11 26 32 2466417
143. Sequential muscle biopsy changes in a case of congenital myopathy. MJ Danon CS Giometti JR Manaligod C Swisher, Muscle Nerve 1997 20 561 569 10.1002/(SICI)1097-4598(199705)20:5<561::AID-MUS4>3.0.CO;2-7 9140362
144. Centronuclear myopathy with special consideration of the adult form. HH Goebel HM Meinck M Reinecke K Schimrigk U Mielke, Eur Neurol 1984 23 425 434 10.1159/000115725 6542524
145. Postnatal centralization of muscle fibre nuclei in centronuclear myopathy. PF van der Ven PH Jap RH Wetzels HJ ter Laak FC Ramaekers AM Stadhouders RC Sengers, Neuromuscul Disord 1991 1 211 220 10.1016/0960-8966(91) 90027-P 1822797
146. Aberrant arrested in maturation neuromuscular junctions in centronuclear myopathy. A Fidzianska HH Goebel, J Neurol Sci 1994 124 83 88 10.1016/0022-510X(94)90015-9 7931426
147. Immunophenotyping of congenital myopathies: disorganization of sarcomeric, cytoskeletal and extracellular matrix proteins. F van der Ven PH Jap HJ ter Laak I Nonaka PG Barth RC Sengers AM Stadhouders FC Ramaekers, J Neurol Sci 1995 129 199 213 10.1016/0022-510X(94)00282-S 7608737
148. Myotubular myopathy: arrest of morphogenesis of myofibres associated with persistence of fetal vimentin and desmin. Four cases compared with fetal and neonatal muscle. HB Sarnat, Can J Neurol Sci 1990 17 109 123 2357647
149. Vimentin and desmin in maturing skeletal muscle and developmental myopathies. HB Sarnat, Neurology 1992 42 1616 1624 1641160
150. The role of immunocytochemistry in congenital myopathies. CA Sewry, Neuromuscular Disorders 1998 8 394 400 10.1016/S0960-8966(98)00053-4 9713857
151. Magnetic resonance imaging of muscle in congenital myopathies associated with RYR1 mutations. H Jungbluth MR Davis C Müller S Counsell J Allsop A Chattopadhyay S Messina E Mercuri NG Laing CA Sewry G Bydder F Muntoni, Neuromuscul Disord 2004 14 12 785 790 10.1016/j.nmd.2004.08.006 15564033
152. Diagnosis of myotubular myopathy in the oldest known manifesting female carrier: a clinical and genetic study. I Pénisson-Besnier V Biancalana P Reynier M Cossée F Dubas, Neuromuscul Disord 2007 17 2 180 185 10.1016/j.nmd.2006.10.008 17251023
153. Diagnosis of X-linked myotubular myopathy by detection of myotubularin. J Laporte W Kress J Mandel, Ann Neurol 2001 50 42 46 10.1002/ana.1033 11456308
154. Myotubular myopathy (centronuclear myopathy). V Dubowitz, Dubowitz V: Muscle biopsy - A practical approach Baillière Tindall 2 1985 443 459
155. Myotubular myopathy associated with cataract and electrical myotonia. CH Hawkes MJ Absolon, J Neurol Neurosurg Psychiatry 1975 38 761 764 1185197
156. Cytopathology of an unusual case of centronuclear myopathy. L. N Hulsmann F Gullotta H Okur, J Neurol Sci 1981 50 311 333 10.1016/0022-510X(81)90146-5 6455504
157. th Naarden, the Netherlands. C Wallgren-Pettersson K Bushby U Mellies A Simonds, Neuromuscul Disord 2003 14 56 69 10.1016/j.nmd.2003.09.003
158. Respiratory involvement in primary muscle disorders: assessment and management. RS Howard CM Wiles NP Hirsch GT Spencer, Q J Med 1993 86 175 189 8483991
159. A follow-up study of congenital non-progressive myopathies. C Akiyama I Nonaka, Brain Dev 1996 18 404 408 10.1016/0387-7604(96)00042-3 8891237
160. Endurance exercise training in a patient with central core disease. UJM Hagberg JE Carroll MH Brooke, Neurology 1980 30 1242 1244 7191522
161. Myopathy and malignant hyperpyrexia. MA Denborough P Ebeling JO King P Zapf, Lancet 1970 1 7657 1138 1140 10.1016/S0140-6736(70)91215-8 4192097
162. Central-core disease and malignant hyperpyrexia. MA Denborough X Dennett RM Anderson, Br Med J 1973 1 272 273 4265427